Connect your AI

Cytek Biosciences, Inc. CTKB Price / book

Price / book at other companies

Becton, Dickinson and CompanyBDX

1.9×-0.8×

Thermo Fisher ScientificTMO

3.5×-0.3×

DanaherDHR

2.5×-0.4×

Fulgent Genetics, Inc.FLGT

0.5×0.0×

10x Genomics, Inc.TXG

3.3×+1.8×

TEC

Bio-TechneTECH

3.9×-0.7×

Other financials

Income statement

Revenue$44.1M+6.5%

Gross profit$21.3M+5.4%

Operating income-$18.5M-23.3%

Net income-$18.9M-65.5%

EPS (diluted)-$0.15-66.7%

Balance sheet

Cash & equivalents$31.8M-66.6%

Total debt$16.8M+40.9%

Total equity$327.6M-13.7%

Total assets$449.1M-6.9%

Cash flow

Operating cash flow-$2.7M-2,089%

CapEx$2.2M+155%

Free cash flow-$4.9M-403%

Valuation

Market cap$577.27M+54.5%

Enterprise value$562.23M+93.7%

P/S2.8×+0.9×

Profitability

Gross margin51.7%-3.2pp

Operating margin-21.5%—

Net margin-36.2%—

FCF margin-6.2%-15.1pp

Returns & leverage

Return on equity-20.9%—

Debt / equity0.1×0.0×

Current ratio4.7×-0.9×

Where this comes from

Calculated from Cytek Biosciences, Inc.’s reported figures.

market cap/total stockholders equity=1.7×

Based on the most recent quarter.

The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cytek Biosciences, Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Cytek Biosciences, Inc.'s price / book?: Cytek Biosciences, Inc. (CTKB) reported price / book of 1.7× in Q1 2026.
How has Cytek Biosciences, Inc.'s price / book changed year-over-year?: Cytek Biosciences, Inc.'s price / book increased by 26.7% year-over-year, from 1.4× to 1.7×.
What is the long-term trend for Cytek Biosciences, Inc.'s price / book?: Over 4 years (2021 to 2025), Cytek Biosciences, Inc.'s price / book has grown at a -23.1% compound annual growth rate (CAGR), from 5.4× to 1.9×.
What does price / book mean?: Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.